These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3042354)

  • 1. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J; Haerlin R; Schäfer N; Christ B; Wurst W
    Drugs; 1988; 35 Suppl 6():147-55. PubMed ID: 3042354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic assessment of urapidil or angiotensin-converting enzyme inhibition in systemic hypertension.
    Rosenthal J; Haerlin R
    Am J Cardiol; 1989 Aug; 64(7):25D-29D. PubMed ID: 2667311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
    Rosenthal J; Haerlin R
    J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A; Haerlin R; Hilgenstock G; Passfall J
    Drugs; 1990; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urapidil and atenolol in hypertension.
    Török E; Wagner M; Podmaniczky M
    Drugs; 1988; 35 Suppl 6():164-72. PubMed ID: 3042356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
    Rumboldt Z; Marinković M; Drinovec J
    Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril.
    Huang PJ; Chien KL; Chen MF; Lai LP; Chiang FT
    Cardiology; 2001; 95(3):146-50. PubMed ID: 11474160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency Room Treatment of Hypertensive Crises.
    Salkic S; Brkic S; Batic-Mujanovic O; Ljuca F; Karabasic A; Mustafic S
    Med Arch; 2015 Oct; 69(5):302-6. PubMed ID: 26622081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
    Stumpe KO; Feldhaus P; Haerlin R
    Fortschr Med; 1989 Jan; 107(1):54-7. PubMed ID: 2646188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of clinical trials with urapidil.
    Schook CE; Radtke H; Wurst W; Thieme G
    Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
    Witte PU; Walter U
    Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril.
    Susalit E; Agus N; Effendi I; Tjandrawinata RR; Nofiarny D; Perrinjaquet-Moccetti T; Verbruggen M
    Phytomedicine; 2011 Feb; 18(4):251-8. PubMed ID: 21036583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
    Schnaper HW
    Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C; Barros LM; Batlouni M; Sousa JE
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.